Little Necessity of Acid Inhibition against Proton Pump Inhibitor Rebound Effects and Prior Helicobacter pylori Eradication Therapy in Gastric Ulcer Patients: A Randomized Prospective Study

被引:0
作者
Wada, Yoshihiro [1 ]
Ito, Masanori [1 ]
Takata, Shunsuke [1 ]
Kitamura, Shosuke [1 ]
Takamura, Akemi [1 ]
Tatsugami, Masana [1 ]
Imagawa, Shinobu [1 ]
Matsumoto, Yoshiaki [1 ]
Tanaka, Shinji [2 ]
Yoshihara, Masaharu [3 ]
Chayama, Kazuaki [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan
[3] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima, Japan
关键词
Helicobacter pylori; Eradication therapy; Gastroesophageal reflux disease (GERD); Proton pump inhibitor (PPI); Atrophic gastritis; REFLUX ESOPHAGITIS; OMEPRAZOLE TREATMENT; SECRETION; HYPERSECRETION; CLASSIFICATION; CANCER;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Helicobacter pylori (H. pylori) eradication therapy increases acid secretion and promotes the development of gastroesophageal reflux disease (GERD) and reflux esophagitis (RE). Rebound acid hypersecretion develops after the use of proton pump inhibitors (PPI). We examined the clinical necessity of acid inhibitors to prevent GERD or RE caused by PPI rebound phenomenon and prior H. pylori eradication therapy. Methodology: We enrolled 39 patients who underwent successful H. pylori eradication therapy prior to endoscopic mucosal resection of gastric cancer. After 8-week rabeprazole treatment for iatrogenic ulcer, they were randomly divided into two groups (who took nizatidine (group N) and sofalcone (group S)), and took each for 16 weeks, we compared RE/GERD symptoms with the baseline by endoscopy and QUEST score. Results: All patients had corpus atrophy in which there was no difference between the two groups. Only 1 patient in group S (5.9%) developed symptomatic GERD, and 1 patient in group N (4.5%) developed RE. Conclusions: In severe atrophic gastritis patients, there is little clinical necessity of acid inhibitors to prevent GERD/RE caused by PPI rebound and prior H. pylori eradication therapy.
引用
收藏
页码:624 / 628
页数:5
相关论文
共 18 条
  • [1] Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers
    Bell, N
    Karol, MD
    Sachs, G
    Greski-Rose, P
    Jennings, DE
    Hunt, RH
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 105 - 113
  • [2] Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023
  • [3] Classification and grading of gastritis - The updated Sydney System
    Dixon, MF
    Genta, RM
    Yardley, JH
    Correa, P
    Batts, KP
    Dahms, BB
    Filipe, MI
    Haggitt, RC
    Haot, J
    Hui, PK
    Lechago, J
    Lewin, K
    Offerhaus, JA
    Price, AB
    Riddell, RH
    Sipponen, P
    Solcia, E
    Watanabe, H
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) : 1161 - 1181
  • [4] Rebound acid hypersecretion after long-term inhibition of gastric acid secretion
    Fossmark, R
    Johnsen, G
    Johanessen, E
    Waldum, HL
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (02) : 149 - 154
  • [5] Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment
    Gillen, D
    Wirz, AA
    McColl, KEL
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : 980 - 988
  • [6] Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
    Gillen, D
    Wirz, AA
    Ardill, JE
    McColl, KEL
    [J]. GASTROENTEROLOGY, 1999, 116 (02) : 239 - 247
  • [7] Endoscopic resection of early gastric cancer
    Gotoda, Takuji
    [J]. GASTRIC CANCER, 2007, 10 (01) : 1 - 11
  • [8] Endoscopic submucosal dissection of early gastric cancer
    Gotoda, Takuji
    Yamamoto, Hironori
    Soetikno, Roy M.
    [J]. JOURNAL OF GASTROENTEROLOGY, 2006, 41 (10) : 929 - 942
  • [9] Hamada H, 2000, ALIMENT PHARM THER, V14, P729
  • [10] Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis
    Hamamoto, N
    Hashimoto, T
    Adachi, K
    Hirakawa, K
    Ishihara, S
    Inoue, H
    Taniura, H
    Niigaki, M
    Sato, S
    Kushiyama, Y
    Suetsugu, H
    Miyake, T
    Kinoshita, Y
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (02) : 281 - 286